Nonspecific anti-inflammatories like steroids might be entirely sidelined for mild-to-moderate chronic hand eczema now that three targeted topical agents are available.
JAK inhibitors approved for atopic dermatitis/eczema include Opzelura (Ruxolitinib), or Rinvoq (Upadacitinib). Vtama cream (tapinarof) is a once-daily steroid-free treatment approved to treat ...